Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03820830
Title Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)
Acronym POLAR
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Breast Cancer Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | HUN | FRA | ESP | CHE | AUT


No variant requirements are available.